![]()
|
|
||||||||
(Received for publication, October 13, 1994; and in revised form, December
19, 1994) We have previously described a mutant B lymphoblastoid cell
line, Clone-13, that expresses HLA-DQ in the absence of HLA-DR and -DP.
Several criteria indicated that the defect in this cell line influences
the activity of an isotype-specific transcription factor. Indeed,
transient transfection of HLA-DRA and DQB reporter constructs indicated
that the affected factor operates via cis-elements located between
-141 base pairs and the transcription initiation site. A series
of hybrid DRA/DQB reporter constructs was generated to further map the
relevant cis-elements in this system. Insertion of oligonucleotides
spanning the DQB X-box (but not the DQB-W region or the DQB Y-box)
upstream of -141 in a DRA reporter plasmid rescued expression to
nearly wild-type levels. Substitution promoters were then generated
where the entire X-box, or only the X1- or X2-boxes of HLA-DRA were
replaced with the analogous regions of HLA-DQB. The DQB X2-box was able
to restore expression to the silent DRA reporter construct. Moreover,
replacement of the DQB X2-box with the DRA X2-box markedly diminished
the activity of the DQB promoter in the mutant cell. None of the hybrid
reporter constructs were defective when transfected into the wild-type,
HLA-DR/-DQ positive parental cell line, Jijoye. These studies suggest
that the divergent X2-box of the class II major histocompatibility
complex promoters plays an important role in influencing differential
expression of the human class II isotypes.
Volume 270,
Number 11,
Issue of March 17, 1995 pp. 6396-6402
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. R. Johnson Locus-Specific Constitutive and Cytokine-Induced HLA Class I Gene Expression J. Immunol., February 15, 2003; 170(4): 1894 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Lennon-Dumenil, M.-R. Barbouche, J. Vedrenne, T. Prod'Homme, M. Bejaoui, S. Ghariani, D. Charron, M. Fellous, K. Dellagi, and C. Alcaide-Loridan Uncoordinated HLA-D Gene Expression in a RFXANK-Defective Patient with MHC Class II Deficiency J. Immunol., May 1, 2001; 166(9): 5681 - 5687. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Itoh-Lindstrom, J. F. Piskurich, N. J. Felix, Y. Wang, W. J. Brickey, J. L. Platt, B. H. Koller, and J. P.-Y. Ting Reduced IL-4-, Lipopolysaccharide-, and IFN-{gamma}-Induced MHC Class II Expression in Mice Lacking Class II Transactivator Due to Targeted Deletion of the GTP-Binding Domain J. Immunol., September 1, 1999; 163(5): 2425 - 2431. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Douhan III, R. Lieberson, J. H.M. Knoll, H. Zhou, and L. H. Glimcher An Isotype-specific Activator of Major Histocompatibility Complex (MHC) Class II Genes That Is Independent of Class II Transactivator J. Exp. Med., June 2, 1997; 185(11): 1885 - 1895. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |